French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

BEIJING, Dec. 3 (Xinhua) -- French pharma giant Sanofi will invest some 1 billion euros (about 1.05 billion U.S. dollars) to establish a new insulin production base in Beijing, according to the ...

A roundup of significant health updates globally includes Sanofi's major investment in China, New Zealand suspending poultry ...

Sanofi has made its single largest investment in China to date by pouring roughly €1 billion ($1.05 billion) into a new ...

Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

On seemingly modest news, Invion shares have gone on a romp as investors grasp the potential of the undervalued cancer drug ...

Zeid Barakat started the discussion by highlighting how, when executed well, CMC represents a key strategic asset. When ...

Current health news highlights include Sanofi's $1 billion investment in a Beijing insulin site, New Zealand's poultry export ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...

French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a ...